Greenwich LifeSciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Greenwich LifeSciences (GLSI).

Price Target Range — 7 Quarters

Analyst Consensus — 1 Analysts

1Buy

Consensus RatingBuy# Analysts1Avg. Consensus PT$69Upside to Avg. PT+324.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Jul 21, 2026	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$50→$69
Dec 30, 2025	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$39→$50
Apr 21, 2025	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$38→$39
Feb 11, 2025	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$38
Aug 23, 2024	HC Wainwright & Co.	Yi Chen	PT Raise	Buy	$36→$38
May 22, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$36
Feb 28, 2024	HC Wainwright & Co.	Yi Chen	Maintained	Buy	$36
Feb 20, 2024	HC Wainwright & Co.	Yi Chen	PT Cut	Buy	$38→$36

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $69

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and raises the price target from $50 to $69.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $50

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and raises the price target from $39 to $50.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $39

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and raises the price target from $38 to $39.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $38 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and maintains $38 price target.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $38

HC Wainwright & Co. analyst Yi Chen maintains Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and raises the price target from $36 to $38.

Benzinga Newsdesk

PRO
HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $36 Price Target

HC Wainwright & Co. analyst Yi Chen reiterates Greenwich LifeSciences (NASDAQ:GLSI) with a Buy and maintains $36 price target.

Benzinga Newsdesk

Greenwich LifeSciences Inc

Greenwich LifeSciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $69

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $50

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $39

PRO
HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $38 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $38

PRO
HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $36 Price Target

People Also Watch

People Also Watch

Greenwich LifeSciences Inc

Greenwich LifeSciences Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROHC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $69

PROHC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $50

PROHC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $39

PROHC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $38 Price Target

PROHC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $38

PROHC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $36 Price Target

People Also Watch

People Also Watch

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $69

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $50

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $39

PRO
HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $38 Price Target

PRO
HC Wainwright & Co. Maintains Buy on Greenwich LifeSciences, Raises Price Target to $38

PRO
HC Wainwright & Co. Reiterates Buy on Greenwich LifeSciences, Maintains $36 Price Target